[Inflammatory diseases of the nervous system. Therapy of encephalitis and myelitis].
D000196:Actinomycosis; D000667:Ampicillin / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001102:Arbovirus Infections; D001419:Bacteria; D001929:Brain Edema / Q000188:drug therapy; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D004668:Encephalitis Viruses; D004679:Encephalomyelitis / Q000628:therapy; D004917:Erythromycin / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D006566:Herpesviridae Infections; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008587:Meningitis, Viral / Q000628:therapy; D008589:Meningococcal Infections / Q000188:drug therapy; D008590:Meningoencephalitis / Q000188:drug therapy; D008712:Methicillin / Q000627:therapeutic use; D009181:Mycoses; D009187:Myelitis / Q000188:drug therapy* / Q000628:therapy; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011528:Protozoan Infections; D012282:Rickettsia Infections; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy
D000927:Anticonvulsants; D000935:Antifungal Agents; D000962:Antimalarials; D002511:Cephalosporins; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D005000:Ethionamide; D008712:Methicillin; D010068:Oxacillin; D013307:Streptomycin
Entzündliche Erkrankungen des Nervensystems. Beitrag zur Therapie von Enzephalitis und Myelitis.